PetCure hits 10,000 radiation patients as access to care expands

PetCure Oncology says it has now treated 10,000 pets with radiation therapy since launching in 2015, a milestone the company is framing as evidence that advanced veterinary radiation has moved beyond a small number of academic centers and into broader referral practice. In its January 7 announcement, the company said it now operates eight treatment centers nationwide and supports referrals with a clinical team that includes 12 board-certified oncologists and eight supervising veterinarians. PetCure’s model centers on stereotactic radiosurgery and stereotactic radiation therapy, which can often be delivered in one to three sessions rather than longer conventional courses. (petcureoncology.com)

Why it matters: For veterinary professionals, the story is less about a round-number milestone and more about access. PetCure’s growth reflects persistent demand for referral radiation options at a time when cancer remains common in dogs and cats, radiation oncology expertise is still limited, and referral pathways can be constrained by geography and specialist availability. Earlier literature on stereotactic radiation in veterinary medicine described the modality as novel, variable in practice, and in need of stronger data-sharing and transparency, underscoring why scale, protocol standardization, and communication with referring veterinarians matter. (petcureoncology.com)

What to watch: Watch whether PetCure’s next phase includes more sites, new platform deployments such as the planned Seattle Sirius system, and more published outcomes data that help primary care and specialty teams decide when referral is most appropriate. (empyreanmed.com)